期刊文献+

A20基因5′上游序列生物信息学分析 被引量:1

The bioinformation of the 5'-flanking region of A20 gene
下载PDF
导出
摘要 目的 A20是一种胞浆瞬时表达蛋白,通过特定的信号通路负反馈调节体内炎症反应。为了解A20基因表达调控炎症的特点,对其5′上游序列进行生物信息学分析,获取基因调控的相关因素。方法从Genebank获取A20基因及其上游序列,利用promter2.0、Transfac 6.0、motif等生物信息学软件分析核转录因子的调控信息。结果结合多种软件分析,A20基因5′上游序列无典型的TATA盒和CAAT盒,且含有多个高度保守的核转录因子结合位点,包括3个与NF-kappa B结合的区域、4个与AP-1结合的区域、1个与HSF结合的位点、1个与Oct-1结合的位点等。结论 A20的表达调控受包括炎症重要核转录因子在内的多种核转录因子的共同调节,且核转录因子之间的协同作用不可忽视。 Objective A20 is the protein of instantaneous expression in the cytoplasm,which takes part in negative adjust inflammation reaction. For understanding the characteristic of A20 in regulating gene expression of inflammation, bioinformaties analyse the A20 gene proximal 5'-flanking region. Methods The A20 gene and 5'-flanking region were obtain from Genebank, the transcriptional factor regulation information was analyzed by Using promoter 2.0 and Tansfae6.0 sofwares. Results It do not exist TATA and CAAT box in the 5'-flanking region of A20 gene. There maybe have three conservative binding sites for NF-κB, four binding sites for AP-1,one binding sites for HSF and one binding sites for Oct-1 . Conclusion many inflammatory transcriptional factors work together for the expression of A20, the synergy among them should not be ignored.
作者 陈潇 吴丽娟
出处 《国际检验医学杂志》 CAS 2010年第10期1059-1061,共3页 International Journal of Laboratory Medicine
基金 军队十一五课题(06MA189)
关键词 锌指 .蛋白 基因 转录因子 NF—κB 计算生物学 zinc fingres egg white Genes transcription factors NF-kappa B computational biology
  • 相关文献

参考文献9

  • 1顾光华,孔祥.泛素蛋白酶体通路以及蛋白酶抑制剂对NF-κB信号通路作用的研究进展[J].实用临床医药杂志,2009,13(5):114-116. 被引量:5
  • 2Barnes PJ,Adock IM.Transcription factor[J].Clin Exp Allergy,1995,25(6):46-49.
  • 3Somboonthum P,Ohta H,Yamada S,et al.Camp-responsire element in TATA-Iess ere promoter is essential for haploid-specific gene expression in mouse testis[J].Nucleic Acids Research,2005,33(8):3401-3411.
  • 4吴丽娟,刘素秀,蒋建新,朱佩芳,康格非.穿膜肽-人A20融合蛋白对单核细胞内毒素应答的影响[J].中华创伤杂志,2006,22(1):45-48. 被引量:5
  • 5Boone DL,Turer EE,Lee EG,et al.The ubiquitin modifying enzyme A20 is required for termination of Toll-like receptor responsesEJ].Nature,2004,5(10):1052-1060.
  • 6Patel VI,Daniel S,Longo CR,et al.A20,a modulator of smooth muscle cell proliferation and apoptosis,prevents and induces regression of neointial hyperplasia[J].FASEB J,2006,20(9):1418-1430.
  • 7Malew ie ZM,Zeller N,Yiln az ZB,et al.NF-κB controls the balance between Fas and tumor necrosis factor cell death pathways during T cell receptor induced apoptosis via the expression of its target gene A20[J].J Biol Chem,2003,278(35):32825-32833.
  • 8Alexandra K,Carol D,Laherty A,et al.Transcriptional activation of the tumor necrosis factor α-Inducible zinc finger protein,A20,is mediated by κB elements[J].The Journal of Biological Chemistry,1992,267(25):17971-17976.
  • 9邓少丽,程小星,袁涛,夏季.BCMA基因5′上游序列生物信息学分析[J].重庆医学,2008,37(3):230-231. 被引量:3

二级参考文献37

  • 1府伟灵,扬茜,张雪.注重生物信息学在检验医学中的应用[J].重庆医学,2004,33(8):1121-1122. 被引量:4
  • 2Wojcik C, DeMartino G N. Intracellular localization of proteasomes[J]. Int J Biochem Cell Biol, 2003, 35: 579.
  • 3Pickatr C M. Back to the future with ubiquitin[J]. Cel, 2004, 116(2): 181.
  • 4Peter M, Voorhees. The Proteasome as a Target for Cancer Therapy[J]. Clinical Cancer Research, 2003, (9): 6316.
  • 5Glickman M, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction[J]. Physiol, 2002, (82): 373.
  • 6Amond J B, Cohen G M. The proteasome, a novel target for cancer hemotherapy[J]. Leukemia, 2002, 16(4): 433.
  • 7Adams J, Palombella V J, Elliott P J. Proteasome inhibition: a new strategy in cancer treatment[J]. Invest New Drugs, 2000, 18: 109.
  • 8Qiao D, Gaitonde S V, Qi W, et al. Deoxycholic acid supprsses p53 by stimulating proteasome-mediated p53 protein degradation[J]. Carcinogenesis, 2001, 22(6): 957.
  • 9Julian A. The proteasome: A suitable antineoplastic target[J]. Cancer, 2004, 4: 349.
  • 10Gao Y, Lecker S. Inhibition of ubiquitin-proteasome pathway-mediated IκB degradation by a naturally occurring antibacterial peptide[J]. Clin invest, 2000, 106: 439.

共引文献10

同被引文献10

  • 1顾玮,单佑安,刘庆,周健,蒋东坡,姚元章,张连阳,都定元,高劲谋,董蕻,杨策,朱佩芳,王正国,蒋建新.汉族人髓样分化蛋白2基因启动子区多态性与严重创伤后并发症易感性的关系[J].中国医学科学院学报,2007,29(4):484-487. 被引量:6
  • 2Wertz IE, 0 ~Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-KB signalling[J].Nature ,2004,430(7000) :694-699.
  • 3Chen J, Zheng H, Bei JX, et al. Genetic structure of the Han Chinese population revealed by genome-wide SNP variation [ J]. Am J Hum Genet,2009,85(6) :775-785.
  • 4Scott LJ,Mohlke KL,Bonnycastle LL, et al. A genome-wide asso- ciation study of type 2 diabetes in Finns detects multiple susceptibility variants[J]. Science,2007,316(5829) :1341-1345.
  • 5Gu W, Shah YA, Zhou J, et al. Functional significance of gene polymorphisrns in the promoter of myeloid differentiation-2 [J]. Ann Surg,2007,246( 1 ) : 151-158.
  • 6Peskulin DD,Fallavena PR,Paludo FJ,et al. TNF-308G >a promoter polymorphism(rs1800629) and outcome from critical illness [ J ]. Braz J Infect Dis,2011,15(3):231-238.
  • 7Cheng JC, Tang NL, Yeung H Y, et al. Genetic association of complex traits:using idiopathic scoliosis as an example[ J]. Clin Orthop Relat Res ,2007,462 ( 1 ) :38--44.
  • 8Ma KK,Banas K,de Bold AJ. Determinants of inducible brain na- triuretie peptide promoter activity[J]. Regul Pept,2005,128(3) :169- 176.
  • 9陈志军,邱勇,王斌,俞杨,朱泽章.江苏汉族人群基因多态性与HapMap数据库的比较[J].江苏医药,2009,35(4):410-414. 被引量:2
  • 10刘毓刚,吴丽娟.A20启动子区rs5029924多态性与创伤后脓毒症易感性的相关性[J].中华创伤杂志,2013,29(7):661-666. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部